Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKT-01 in Uncontrolled Lupus Nephritis
NCT00709722Phase 2Completed
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Oct 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of deoxyspergualin in lupus nephritis (LN), sponsored by Nippon Kayaku Co., Ltd.. Started Oct 2003; status: completed.
02
Drugs
deoxyspergualin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00709722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709722.